PregLem Company

PregLem is a Swiss biopharmaceutical company that focuses on developing and selling innovative drugs for women's reproductive medicine.

Headquarters: Geneva
Industry: Reproductive Health & Contraception
Employee Number: 11-50
Investors Number: 4
Funding Status: M&A
Last Funding Type: Series B
Founded Date: 2006
Total Funding: $58,248,124
Last Funding Date: 2007-12-04